Genelux Corp. (GNLX)
NASDAQ · Healthcare
Genelux Corp. Shareholder Equity 2022–2025
Genelux Corp. annual shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Genelux Corp. shareholder equity as of December 31, 2025: 11.5M, a 56.06% decrease year-over-year.
- Genelux Corp. shareholder equity for 2025 were 11.5M, a 56.06% decrease from 2024.
- Genelux Corp. shareholder equity for 2024 were 26.3M, a 34.93% increase from 2023.
- Genelux Corp. shareholder equity for 2023 were 19.5M, a 154.42% decrease from 2022.
- Genelux Corp. shareholder equity for 2022 were -35.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Genelux Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $12 |
| 2024 | $26 |
| 2023 | $19 |
| 2022 | $-36 |
Genelux Corp. Shareholder Equity — FAQ
Genelux Corp. (GNLX) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GNLX's shareholder equity history?
The chart and table above show Genelux Corp.'s shareholder equity by year and by quarter, including the growth rate.